Notice: This company has been marked as potentially delisted and may not be actively trading. Cesca Therapeutics (KOOL) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsDividendTrendsBuy This Stock KOOL vs. THMO, KEQU, ACHV, KYTX, ANIX, MIST, BMEA, BDTX, QIPT, and MGRMShould you be buying Cesca Therapeutics stock or one of its competitors? The main competitors of Cesca Therapeutics include ThermoGenesis (THMO), Kewaunee Scientific (KEQU), Achieve Life Sciences (ACHV), Kyverna Therapeutics (KYTX), Anixa Biosciences (ANIX), Milestone Pharmaceuticals (MIST), Biomea Fusion (BMEA), Black Diamond Therapeutics (BDTX), Quipt Home Medical (QIPT), and Monogram Orthopaedics (MGRM). Cesca Therapeutics vs. ThermoGenesis Kewaunee Scientific Achieve Life Sciences Kyverna Therapeutics Anixa Biosciences Milestone Pharmaceuticals Biomea Fusion Black Diamond Therapeutics Quipt Home Medical Monogram Orthopaedics ThermoGenesis (NASDAQ:THMO) and Cesca Therapeutics (NASDAQ:KOOL) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, media sentiment, dividends, analyst recommendations, community ranking and profitability. Which has more risk & volatility, THMO or KOOL? ThermoGenesis has a beta of 2.47, indicating that its share price is 147% more volatile than the S&P 500. Comparatively, Cesca Therapeutics has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500. Do institutionals and insiders believe in THMO or KOOL? 5.8% of ThermoGenesis shares are held by institutional investors. Comparatively, 3.1% of Cesca Therapeutics shares are held by institutional investors. 78.0% of ThermoGenesis shares are held by company insiders. Comparatively, 68.9% of Cesca Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has stronger valuation & earnings, THMO or KOOL? ThermoGenesis has higher earnings, but lower revenue than Cesca Therapeutics. Cesca Therapeutics is trading at a lower price-to-earnings ratio than ThermoGenesis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThermoGenesis$9.61M0.00-$17.98M-$5.14N/ACesca Therapeutics$9.67M2.58-$39.72M-$3.60-2.87 Does the media favor THMO or KOOL? In the previous week, ThermoGenesis' average media sentiment score of 0.00 equaled Cesca Therapeutics'average media sentiment score. Company Overall Sentiment ThermoGenesis Neutral Cesca Therapeutics Neutral Is THMO or KOOL more profitable? ThermoGenesis has a net margin of 0.00% compared to Cesca Therapeutics' net margin of -98.84%. ThermoGenesis' return on equity of 0.00% beat Cesca Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets ThermoGenesisN/A N/A N/A Cesca Therapeutics -98.84%-77.30%-37.75% Does the MarketBeat Community prefer THMO or KOOL? Cesca Therapeutics received 241 more outperform votes than ThermoGenesis when rated by MarketBeat users. Likewise, 70.45% of users gave Cesca Therapeutics an outperform vote while only 60.47% of users gave ThermoGenesis an outperform vote. CompanyUnderperformOutperformThermoGenesisOutperform Votes2660.47% Underperform Votes1739.53% Cesca TherapeuticsOutperform Votes26770.45% Underperform Votes11229.55% SummaryThermoGenesis beats Cesca Therapeutics on 7 of the 11 factors compared between the two stocks. Remove Ads Get Cesca Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KOOL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KOOL vs. The Competition Export to ExcelMetricCesca TherapeuticsLaboratory Apparatus & Furniture IndustryMedical SectorNASDAQ ExchangeMarket Cap$24.93M$112.43M$5.63B$7.79BDividend Yield0.50%N/A5.37%4.05%P/E Ratio-2.876.2423.6018.68Price / Sales2.580.51374.3389.80Price / CashN/A45.3038.1734.64Price / Book3.322.906.754.12Net Income-$39.72M$18.75M$3.20B$247.10M Cesca Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KOOLCesca TherapeuticsN/A$10.32+0.7%N/AN/A$24.93M$9.67M-2.8753News CoverageTHMOThermoGenesisN/AN/AN/AN/A$2,000.00$9.61M0.0040KEQUKewaunee Scientific2.948 of 5 stars$44.96-3.3%N/A+14.5%$128.36M$220.03M7.131,006Positive NewsGap DownACHVAchieve Life Sciences2.0055 of 5 stars$2.97+5.7%$15.75+430.3%-41.3%$103.01MN/A-2.6320Positive NewsKYTXKyverna Therapeutics1.5721 of 5 stars$2.35-1.3%$18.40+683.0%-92.2%$102.75M$7.03M0.0096Earnings ReportANIXAnixa Biosciences3.1319 of 5 stars$3.20+1.3%$9.00+181.3%-8.3%$101.74M$210,000.00-8.215Gap UpMISTMilestone Pharmaceuticals2.3161 of 5 stars$2.05+7.9%$17.00+729.3%-55.3%$101.37M$1M-2.5330High Trading VolumeBMEABiomea Fusion2.9476 of 5 stars$2.79-2.8%$29.18+945.9%-85.8%$101.11MN/A-0.7050Earnings ReportUpcoming EarningsAnalyst ForecastNews CoverageGap DownBDTXBlack Diamond Therapeutics3.3571 of 5 stars$1.68-5.6%$14.60+769.0%-69.4%$100.86MN/A-1.2690Positive NewsHigh Trading VolumeQIPTQuipt Home Medical2.5967 of 5 stars$2.34-1.3%$6.25+167.1%-46.7%$100.83M$244.72M-13.76800MGRMMonogram Orthopaedics2.8493 of 5 stars$2.84-10.7%$5.40+90.1%+20.5%$100.22M$364,999.00-6.0428 Remove Ads Related Companies and Tools Related Companies THMO Alternatives KEQU Alternatives ACHV Alternatives KYTX Alternatives ANIX Alternatives MIST Alternatives BMEA Alternatives BDTX Alternatives QIPT Alternatives MGRM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KOOL) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored“Massive Financial Reset Is Coming”The U.S. markets will see a massive reset, beginning days from now. But the "reset" isn't what you might ex...InvestorPlace | SponsoredGold Hits $3,000… Here’s How You Can Get More for Under $20With gold surging to record highs, currently trading above $3,000 an ounce, and central banks aggressively sto...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cesca Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cesca Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
